MERISCREEN COVID-19 Antigen Detection Test
Manufactured by Meril Diagnostics Pvt Ltd., India - www.merillife.com
Device identification number
HSC common list (RAT)
Lab-based, Near POC / POC
Cassette, Lateral flow, Strip
Cross-reactivity (pathogens tested)
B.1.1.7 (Alpha), B.1.351 (Beta), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.525 (Eta), B.1.526 (Iota), B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3, C.37 (Lambda), P.1 (Gamma), P.2 (Zeta), P.3 (Theta)
2022-08-24 09:08:01 CET
The product is clinically tested, validated and approved by Indian council of medical research (ICMR). Notified with European Union with the EU Representative Obelis SA from Belgium having EAR certificate.
MERISCREEN COVID-19 Antigen Detection Test is ≥ 933 TCID50/ml.
Analysis of cross reactivity
0 % The product is having zero False positive, specificity is 100%
2.88 % (The product is having sensitivity of 97.12%, Gives 2.88% false negative results)
Type of antigen
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements